Is a complete CNXU research report available?

No complete published report is available for Conexeu Sciences Inc. (CNXU) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Conexeu Sciences Inc. (CNXU)

NASDAQ: CNXU · USD

$8.83

+0.94 (+11.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CNXU analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	236.3M
Net income (ttm)	-7.2M
EPS (ttm)	-$0.39
Shares out	26.8M
Volume	161,373

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -7.2M
EPS (ttm): -$0.39
Market cap: 236.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CNXU indicators

Market & fundamental data

Available fields

135

Groups with data

Currency

USD

Showing 135 of 135 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002066836
Company name	Conexeu Sciences Inc.
Country	United States
Country code	US
Cusip	20715F100
Enterprise value	$232.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-07-12
Industry	Biotechnology
Isin	US20715F1003
Last refreshed	2026-07-31
Market cap	$236.3M
Market cap category	Micro-Cap
Price	$8.83
Price currency	USD
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	3842
Symbol	CNXU
Website	https://www.conexeu.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.01%
FCF yield	-1.83%
P/B ratio	22.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-7.2M
Net Income Growth Years	0%
ROCE	-101.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$8.2M
Cash	$6.8M
Current Assets	$7.9M
Current Liabilities	$1M
Debt	$3,722
Debt Equity	$0
Equity	$7.2M
Liabilities	$1M
Long Term Assets	$285,994
Long Term Liabilities	$0
Net Cash	$6.8M
Net Cash By Market Cap	$2.86
Net Cash Growth	3,181.29%
Net Debt Equity	$-0.95
Tangible Book Value	$7M
Tangible Book Value Per Share	$0.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.89
Net Working Capital	$66,047
Quick ratio	6.83
Working Capital	$6.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-172.26%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	18.79
All Time High Change	-53.01%
All Time High Date	2026-06-03
All Time Low	7.1
All Time Low Change	24.37%
All Time Low Date	2026-07-28
ATR	1.39
Beta1y	-3.26
High	8.95
High52	18.79
High52 Date	2026-06-03
High52ch	-53.01%
Low	7.76
Low52	7.1
Low52 Date	2026-07-28
Low52ch	24.37%
Premarket Change Percent	3.3
Premarket Price	$8.15
RSI	44.06
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-0.76x
Sortino ratio	-1.17
Total Return	-172.26%
Tr1m	-13.77%
Tr1w	-3.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-7.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,560,742%
Float Percent	58.15%
Net Borrowing	3,911
Shares Insiders	35.12%
Shares Out	26,758,330
Shares Qo Q	2.43%
Shares Yo Y	172.26%
Short Float	1.1%
Short Ratio	1.61
Short Shares	0.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7M
Adjusted OCF	-6,957,713
Average Volume	138,881.15x
Bv Per Share	0.34
CAPEX	$-35,229
Ch1m	-13.77
Ch1w	-3.5
Change	11.91%
Change From Open	7.68
Close	7.89
Days Gap	3.93
Depreciation Amortization	31,146
Dollar Volume	1,424,923.6
Earnings Date	2026-09-14
EBIT	$-7.3M
EBITDA	$-7.2M
EPS	$-0.39
F Score	2
FCF	$-4.4M
FCF EV Yield	-1.88x
FCF Per Share	$-0.16
Financing CF	11,678,721
Fiscal Year End	October
Founded	2,022
Investing CF	-106,557
Is Primary Listing	1
Is Spac	No
Last Report Date	2026-04-30
Last Split Type	Never
Ma20	9.53
Ma20ch	-7.36%
Net CF	7,222,602
Next Earnings Date	2026-09-14
Open	8.2
Position In Range	89.92
Post Close	8.83
Postmarket Change Percent	0.22
Postmarket Price	$8.85
Ppne	38,400
Pre Close	7.89
Price Date	2026-07-30
Ptbv Ratio	34.05
Relative Volume	1.16x
Share Based Comp	2,612,062
Us State	Nevada
Volume	161,373

Conexeu Sciences Inc. (CNXU)

Coverage state: Market snapshot only — no published research

Generate the first CNXU analysis

Price

Financial snapshot

Fair-value bridge

Latest news · CNXU

Valuation

Balance sheet

Trading

Next earnings

Sector percentile context

All CNXU indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CNXU

Frequently asked questions